Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

July 24, 2018; 91 (4) Article

Subjective cognitive decline and risk of MCI

The Mayo Clinic Study of Aging

Argonde C. van Harten, Michelle M. Mielke, Dana M. Swenson-Dravis, Clinton E. Hagen, Kelly K. Edwards, Rosebud O. Roberts, Yonas E. Geda, David S. Knopman, Ronald C. Petersen
First published June 29, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005863
Argonde C. van Harten
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle M. Mielke
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana M. Swenson-Dravis
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clinton E. Hagen
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly K. Edwards
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosebud O. Roberts
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
MBChB, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yonas E. Geda
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. Knopman
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald C. Petersen
From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Short Form
Citation
Subjective cognitive decline and risk of MCI
The Mayo Clinic Study of Aging
Argonde C. van Harten, Michelle M. Mielke, Dana M. Swenson-Dravis, Clinton E. Hagen, Kelly K. Edwards, Rosebud O. Roberts, Yonas E. Geda, David S. Knopman, Ronald C. Petersen
Neurology Jul 2018, 91 (4) e300-e312; DOI: 10.1212/WNL.0000000000005863

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
673

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective We investigated different dimensions of subjective cognitive decline (SCD) to determine which was the best prognostic risk factor for incident mild cognitive impairment (MCI) among cognitively unimpaired participants.

Methods We included 1,167 cognitively unimpaired participants, aged 70 to 95 years, from the Mayo Clinic Study of Aging based on 2 concurrent SCD scales (part of the Blessed memory test and the 39-item Everyday Cognition [ECog] scale, which included a validated 12-item derivative) and a single question assessing worry about cognitive decline. We evaluated multiple ways to dichotomize scores. In continuous models, we compared average scores on 4 ECog domains and multidomain (39- and 12-item) ECog scores. Cox proportional hazards models were used to assess the association between each measure and risk of MCI in models adjusted for objective memory performance, depression, anxiety, sex, APOE ε4 carriership, and medical comorbidities.

Results It was possible to select a substantial group of participants (14%) at increased risk of incident MCI based on combined baseline endorsement of any consistent SCD on the ECog (any item scored ≥3; 12-item ECog hazard ratio [HR] 2.17 [95% confidence interval 1.51–3.13]) and worry (HR 1.79 [1.24–2.58]) in an adjusted model combining these dimensions. In continuous models, all ECog domains and the multidomain scores were associated with risk of MCI with a small advantage for multidomain SCD (12-item ECog HR 2.13 [1.36–3.35] per point increase in average score). Information provided by the informant performed comparable to self-perceived SCD.

Conclusion Prognostic value of SCD for incident MCI improves when both consistency of SCD and associated worry are evaluated.

Glossary

AD=
Alzheimer disease;
ADNI=
Alzheimer's Disease Neuroimaging Initiative;
AgeCoDe study=
German Study on Ageing, Cognition, and Dementia;
CU=
cognitively unimpaired;
ECog=
Everyday Cognition;
HR=
hazard ratio;
iECog=
informant-based Everyday Cognition;
iSCD=
informant-based subjective cognitive decline;
MCI=
mild cognitive impairment;
MCSA=
Mayo Clinic Study of Aging;
SCD=
subjective cognitive decline

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Editorial, page 153

  • Received December 21, 2017.
  • Accepted in final form April 13, 2018.
  • © 2018 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hastening the Diagnosis of Amyotrophic Lateral Sclerosis

Dr. Brian Callaghan and Dr. Kellen Quigg

► Watch

Related Articles

  • Not all, but specific types of cognitive complaints predict decline to MCI

Topics Discussed

  • Alzheimer's disease
  • Prognosis
  • Cognitive aging
  • MCI (mild cognitive impairment)

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Quantity and quality of mental activities and the risk of incident mild cognitive impairment
    Janina Krell-Roesch, Jeremy A. Syrjanen, Maria Vassilaki et al.
    Neurology, July 10, 2019
  • Article
    Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults
    Alexandra J. Weigand, Mark W. Bondi, Kelsey R. Thomas et al.
    Neurology, September 02, 2020
  • Article
    Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
    Steffen Wolfsgruber, Frank Jessen, Alexander Koppara et al.
    Neurology, February 25, 2015
  • Editorial
    Not all, but specific types of cognitive complaints predict decline to MCI
    Frank Jessen, Francisca S. Rodriguez (née Then) et al.
    Neurology, June 29, 2018
Neurology: 101 (20)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise